We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

3036:TWSEWT Microelectronics Co., Ltd. Analysis

Data as of 2026-05-26 - not real-time

NT$293.00

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

WT Microelectronics is trading well above its short‑ and medium‑term moving averages, confirming a bullish price trajectory supported by a bullish MACD histogram. The stock’s RSI is elevated, indicating that momentum may be peaking and that a short‑term pull‑back could be on the horizon.
Fundamentally, earnings are accelerating sharply – forward EPS is expected to be nearly three times the trailing figure – and the forward P/E has collapsed to a single‑digit level, suggesting attractive valuation relative to earnings growth. However, the discounted cash‑flow model places fair value well below the current price, flagging a potential overvaluation risk. The dividend yield of roughly 2.6% is backed by a payout ratio under 60%, which points to reasonable sustainability despite modest operating cash‑flow deficits. Overall, the stock offers strong growth drivers and a solid dividend, but price momentum and valuation concerns temper enthusiasm for immediate buying.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD but elevated RSI suggests near‑term overbought conditions
  • Price approaching a key resistance level around the 52‑week high
  • Stable trading volume supports liquidity for short‑term positioning

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong forward earnings growth and a forward P/E in the low‑single digits
  • Attractive dividend yield with a sustainable payout ratio
  • Industry tailwinds in automotive, datacenter and consumer electronics

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • DCF fair‑value gap indicates the current price may be stretched
  • Consistent revenue base and diversified geographic exposure
  • Moderate leverage and solid return on equity support long‑run stability

Key Metrics & Analysis

Financial Health

Revenue Growth99.80%
Profit Margin1.25%
P/E Ratio28.4
ROE16.16%
ROA2.97%
Debt/Equity84.92
P/B Ratio3.4
Op. Cash FlowNT$-3653931008
Free Cash FlowNT$6.8B
Industry P/E39.5

Technical Analysis

TrendBullish
RSI68.8
SupportNT$199.00
ResistanceNT$308.00
MA 20NT$252.75
MA 50NT$238.14
MA 200NT$168.64
MACDBullish
VolumeStable
Fear & Greed Index91.8

Valuation

Fair ValueNT$145.47
Target PriceNT$310.57
Upside/Downside6.00%
GradeOvervalued
TypeGrowth
Dividend Yield2.59%

Risk Assessment

Beta0.15
Volatility58.26%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.